131 related articles for article (PubMed ID: 37059250)
1. The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels.
Choi NR; Kwon MJ; Choi WG; Kim SC; Park JW; Nam JH; Kim BJ
J Ethnopharmacol; 2023 Aug; 312():116499. PubMed ID: 37059250
[TBL] [Abstract][Full Text] [Related]
2.
Choi NR; Choi WG; Lee JH; Park J; Kim YT; Das R; Woo JH; Kim BJ
Nutrients; 2024 May; 16(11):. PubMed ID: 38892616
[TBL] [Abstract][Full Text] [Related]
3. The Traditional Medicine Banhasasim-Tang Depolarizes Pacemaker Potentials of Cultured Interstitial Cells of Cajal through M3 Muscarinic and 5-HT3 Receptors in Murine Small Intestine.
Kim JN; Nam JH; Lee JR; Kim SC; Kim BJ
Digestion; 2020; 101(5):536-551. PubMed ID: 31185476
[TBL] [Abstract][Full Text] [Related]
4. Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.
Park BK; Chun E; Choi JJ; Shin Y; Kho YT; Oh SH; Kim SY; Lee TH; Kim TW; Shin E; Do SG; Jin M
J Med Food; 2017 May; 20(5):474-484. PubMed ID: 28452565
[TBL] [Abstract][Full Text] [Related]
5. Alleviation of Irritable Bowel Syndrome-Like Symptoms and Control of Gut and Brain Responses with Oral Administration of
Chun E; Yoon S; Parveen A; Jin M
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30309025
[TBL] [Abstract][Full Text] [Related]
6. Traditional Herbal Formula Banhasasim-tang Exerts Anti-Inflammatory Effects in RAW 264.7 Macrophages and HaCaT Keratinocytes.
Jin SE; Lim HS; Kim Y; Seo CS; Yoo SR; Shin HK; Jeong SJ
Evid Based Complement Alternat Med; 2015; 2015():728380. PubMed ID: 25838833
[TBL] [Abstract][Full Text] [Related]
7. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction.
Zhang C; Huang Y; Li P; Chen X; Liu F; Hou Q
BMC Complement Med Ther; 2020 Sep; 20(1):279. PubMed ID: 32928188
[TBL] [Abstract][Full Text] [Related]
8. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a High-Performance Liquid Chromatography Method to Quantify Marker Compounds in
Kim HY; Kim CE; Oh DR; Kim Y; Choi CY; Kim J
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611770
[TBL] [Abstract][Full Text] [Related]
10. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.
Brenner DM; Sayuk GS
Adv Ther; 2020 Jan; 37(1):83-96. PubMed ID: 31707713
[TBL] [Abstract][Full Text] [Related]
11. [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
Shi H; Niu Y; Huang Q; Yang ZM; Yang L
Zhongguo Zhen Jiu; 2021 Sep; 41(9):984-90. PubMed ID: 34491647
[TBL] [Abstract][Full Text] [Related]
12. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
Hawrelak JA; Myers SP
J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
[TBL] [Abstract][Full Text] [Related]
13. Single Oral Acute Toxicity of Banhasasim-Tang and Its Antiobesity Effect on Diet-Induced Obese Mice and 3T3-L1 Adipocytes.
Yoo SR; Jeong SJ; Lee MY; Shin HK; Seo CS; Ha H
Evid Based Complement Alternat Med; 2018; 2018():3865434. PubMed ID: 30228826
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic effect of banhasasim-tang on chronic acid reflux esophagitis.
Shin MR; An HJ; Seo BI; Roh SS
World J Gastroenterol; 2017 Jul; 23(25):4644-4653. PubMed ID: 28740353
[TBL] [Abstract][Full Text] [Related]
15. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased Na
Strege PR; Mazzone A; Bernard CE; Neshatian L; Gibbons SJ; Saito YA; Tester DJ; Calvert ML; Mayer EA; Chang L; Ackerman MJ; Beyder A; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G494-G503. PubMed ID: 29167113
[TBL] [Abstract][Full Text] [Related]
17. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effect of herb-separated moxibustion at Jinsuo (GV 8)-eight-diagram points on diarrhea-type irritable bowel syndrome of liver stagnation and spleen deficiency].
Hao LJ; Shi ZM
Zhongguo Zhen Jiu; 2020 Jul; 40(7):702-6. PubMed ID: 32648391
[TBL] [Abstract][Full Text] [Related]
19. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
[TBL] [Abstract][Full Text] [Related]
20. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
Wang XX; Luo RJ; She B; Chen Y; Guo J
Trials; 2014 Jul; 15():273. PubMed ID: 25002196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
